Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study

Neuro-oncology
Louis Burt NaborsDavid A Reardon

Abstract

Survival outcomes for patients with glioblastoma remain poor, particularly for patients with unmethylated O(6)-methylguanine-DNA methyltransferase (MGMT) gene promoter. This phase II, randomized, open-label, multicenter trial investigated the efficacy and safety of 2 dose regimens of the selective integrin inhibitor cilengitide combined with standard chemoradiotherapy in patients with newly diagnosed glioblastoma and an unmethylated MGMT promoter. Overall, 265 patients were randomized (1:1:1) to standard cilengitide (2000 mg 2×/wk; n = 88), intensive cilengitide (2000 mg 5×/wk during wk 1-6, thereafter 2×/wk; n = 88), or a control arm (chemoradiotherapy alone; n = 89). Cilengitide was administered intravenously in combination with daily temozolomide (TMZ) and concomitant radiotherapy (RT; wk 1-6), followed by TMZ maintenance therapy (TMZ/RT→TMZ). The primary endpoint was overall survival; secondary endpoints included progression-free survival, pharmacokinetics, and safety and tolerability. Median overall survival was 16.3 months in the standard cilengitide arm (hazard ratio [HR], 0.686; 95% CI: 0.484, 0.972; P = .032) and 14.5 months in the intensive cilengitide arm (HR, 0.858; 95% CI: 0.612, 1.204; P = .3771) versus 13.4 month...Continue Reading

References

Jul 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D R MacdonaldJ G Cairncross
Mar 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Monika E HegiRoger Stupp
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Mar 11, 2005·The New England Journal of Medicine·Monika E HegiRoger Stupp
May 2, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L Burt NaborsStuart A Grossman
Nov 5, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David A ReardonL Burt Nabors
Feb 10, 2009·International Journal of Cancer. Journal International Du Cancer·Tom MikkelsenSimon L Goodman
Dec 24, 2009·Nature Reviews. Cancer·Jay S Desgrosellier, David A Cheresh
Mar 17, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patrick Y WenSusan M Chang
May 5, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roger StuppMichael Weller
Jan 10, 2012·Neurochemical Research·Catherine P HaarNaren L Banik
Apr 21, 2012·Cancer·L Burt NaborsUNKNOWN New Approaches to Brain Tumor Therapy (NABTT) Central Nervous System Consortium

❮ Previous
Next ❯

Citations

Oct 20, 2015·Journal of Neuro-oncology·J J RaizerUNKNOWN Brain Tumor Trials Collaborative
Dec 10, 2015·BMC Medicine·Brett J Theeler, Mark R Gilbert
Nov 13, 2015·Future Oncology·Evidio Domingo-Musibay, Evanthia Galanis
Mar 20, 2016·Brain Tumor Pathology·Toshihiko ShimizuIsao Date
Apr 2, 2016·Bulletin du cancer·Antoine SchernbergFrédéric Dhermain
Apr 8, 2016·Expert Opinion on Pharmacotherapy·Katharina SeystahlMichael Weller
Nov 1, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·A Dullea, L Marignol
Jun 4, 2016·Angewandte Chemie·Carlos Mas-MorunoHorst Kessler
Jul 31, 2016·Current Opinion in Cell Biology·Fevzi Demircioglu, Kairbaan Hodivala-Dilke
Sep 1, 2014·Seminars in Oncology·Derek R Johnson, Evanthia Galanis
Oct 22, 2016·Thrombosis Journal·Tur-Fu HuangYu-Ju Kuo
Jan 24, 2017·Future Medicinal Chemistry·Aleksandra Ellert-MiklaszewskaBozena Kaminska
Jan 21, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Caroline HappoldMichael Weller
Mar 16, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ulrich HerrlingerMartin Glas
Oct 11, 2017·Neuro-oncology·Evanthia GalanisUNKNOWN Alliance for Clinical Trials in Oncology and ABTC
Feb 10, 2018·Journal of Neuro-oncology·Caroline HappoldUNKNOWN EORTC Brain Tumor Group and on behalf of the CENTRIC and CORE Clinical Trial Groups
Jun 24, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brian M Alexander, Timothy F Cloughesy
Feb 22, 2018·Glia·Valéria Pereira FerrerRolf Mentlein
Jul 12, 2018·Journal of Cell Science·Pavlo G Gritsenko, Peter Friedl
Nov 28, 2018·The Cochrane Database of Systematic Reviews·Malaka AmeratungaMustafa Khasraw
Aug 20, 2018·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Hyeon Kang KohIl Han Kim
Oct 12, 2017·Journal of Oncology Practice·Joo Yeon Nam, John F de Groot
Apr 14, 2019·International Journal of Cancer. Journal International Du Cancer·Corinna SeligerUNKNOWN EORTC Brain Tumor Group
Feb 6, 2020·International Journal of Molecular Sciences·Aleksandra Ellert-MiklaszewskaBozena Kaminska
Mar 17, 2017·Neurology·Dorothee GramatzkiMichael Weller
Mar 24, 2020·The Cochrane Database of Systematic Reviews·Catherine HannaRobin Grant
May 13, 2020·The Cochrane Database of Systematic Reviews·Adrian LeeHelen Wheeler
Feb 28, 2015·Surgical Neurology International·Emilie Le RhunMarc C Chamberlain
Oct 30, 2016·Journal of Thrombosis and Haemostasis : JTH·C J McDonnellS W Kerrigan
Apr 4, 2017·Memo·Christine Marosi, Matthias Preusser
Aug 24, 2017·Cancers·Sabine Raab-WestphalSimon L Goodman
Sep 5, 2017·Cancers·Markus NieberlerHorst Kessler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.